Progyny Inc
Closed
SectorHealthcare
25.41 -0.86
Overview
Share price change
24h
Min
25.33
Max
25.84
Income | 12M 24M |
|---|---|
Sales | 10M 329M |
P/E Sector Avg | 32.312 50.102 |
EPS | 0.29 |
Profit margin | 7.376 |
Employees | 835 |
EBITDA | 16M 35M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +13.46% upside |
Next Earnings | 6 sie 2026 |
|---|
Market Cap | 400M 1.9B |
|---|---|
Previous open | 26.27 |
Previous close | 25.41 |
Progyny Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Progyny Inc Forecast
Price Target
By TipRanks
13.46% upside
12 Months Forecast
Average 29 USD 13.46%
High 31 USD
Low 26 USD
Based on 9 Wall Street analysts offering 12 month price targets forProgyny Inc - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Progyny Inc
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
